Expert Strategies in MCL: Age-Based Differential Approaches to Induction Therapy

June 13, 2014

The program is a live, complementary, educational symposium held in conjunction with the 2014 Pan Pacific Lymphoma Conference

Join us for this accredited activity focusing on the use of induction therapy in older versus younger patients with mantle cell lymphoma (MCL). The program is a live, complementary, educational symposium held in conjunction with the 2014 Pan Pacific Lymphoma Conference.

Through discussion of current treatments, emerging therapies, and evolving therapeutic strategies, participants will gain insight into clinical approaches that are considered best practices in MCL, as well as into patient types whose clinical stage and/or genetic makeup require more aggressive treatment strategies.

Faculty will not only present the most current data concerning induction therapy in MCL, but will also apply this information through discussion of interactive case studies that exemplify how these therapeutic strategies may be applied in actual clinical practice.

Julie M. Vose, MD, MBA — Chair

University of Nebraska Medical Center

Omaha, Nebraska

John P. Leonard, MD

Weill Cornell Medical College

New York, New York

Brad S. Kahl, MD

University of Wisconsin School of Medicine

and Public Health

Madison, Wisconsin

Click Here to register now and learn more about this live educational event.